Composition with effect of reducing blood pressure and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and technology for lowering blood pressure, which is applied in the field of medicine, health care products or food, can solve problems such as damage to the regulation mechanism, difficulty in quality control, complex composition, etc., and achieve the effect of controlling blood pressure, lowering blood pressure, and good therapeutic effect
Pending Publication Date: 2020-03-31
重庆申高生化制药股份有限公司
View PDF3 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Commonly used chemical synthetic drugs include: diuretic and antihypertensive drugs, vasodilator smooth muscle dilators, angiotensin-converting enzyme inhibitors (ACEI), calcium antagonists, adrenergic receptor blockers, angiotensin II receptor antagonists (AIIRB ), etc., these drugs are mainly aimed at the symptoms of high blood pressure, and achieve the purpose of controlling blood pressure by blocking or alleviating the body's own blood pressure rising mechanism, but this will destroy the body's own regulation mechanism, and the side
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0027] The composition with blood pressure-lowering effect of this implementation includes the following raw material components in parts by weight: 5 parts of soybean peptide, 1 part of raspberry extract, 1 part of Rhodiola rosea extract, 1 part of Polygonatum extract, grape seed 1 part of extract, 1 part of green tea extract, 1 part of Moringa leaf extract, 0.5 part of theanine, 0.5 part of astaxanthin, 0.5 part of lycopene, 0.5 part of resveratrol, 0.5 part of curcumin, EPA 0.1 part, DHA 0.1 part, cyanidin 0.1 part, delphinidin 0.1 part.
Embodiment 2
[0029] The composition with blood pressure lowering effect of this embodiment includes the following raw material components in parts by weight: 15 parts of soybean peptide, 3 parts of raspberry extract, 3 parts of Rhodiola rosea extract, 3 parts of Polygonatum extract, grape 3 parts of seed extract, 3 parts of green tea extract, 3 parts of Moringa leaf extract, 2 parts of theanine, 2 parts of astaxanthin, 2 parts of lycopene, 2 parts of resveratrol, 2 parts of curcumin, 1 part of EPA, 1 part of DHA, 1 part of cyanidin, and 1 part of delphinidin.
[0030] Implementation three
[0031] The composition with antihypertensive effect of this embodiment includes the following raw material components in parts by weight: 5 parts of soybean peptide, 3 parts of raspberry extract, 1 part of Rhodiola rosea extract, 3 parts of Polygonatum extract, grape 1 part of seed extract, 3 parts of green tea extract, 1 part of Moringa leaf extract, 2 parts of theanine, 0.5 part of astaxanthin, 2 par...
Embodiment 4
[0033] The composition with blood pressure lowering effect of this embodiment includes the following raw material components in parts by weight: 15 parts of soybean peptide, 1 part of raspberry extract, 3 parts of Rhodiola rosea extract, 1 part of Polygonatum extract, grape 3 parts of seed extract, 1 part of green tea extract, 3 parts of Moringa leaf extract, 0.5 parts of theanine, 2 parts of astaxanthin, 0.5 parts of lycopene, 2 parts of resveratrol, 0.5 parts of curcumin, 1 part of EPA, 0.1 part of DHA, 1 part of cyanidin, and 0.1 part of delphinidin.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a composition with an effect of reducing blood pressure. The composition comprises the following raw materials, by weight: 5 to 15 parts of soybean peptide, 1 to 3 parts of raspberry extract, 1 to 3 parts of rhodiola rosea extract, 1 to 3 parts of rhizoma polygonati extract, 1 to 3 parts of grape seed extract, 1 to 3 parts of green tea extract, 1 to 3 parts of horseradish tree leaf extract, 0.5 to 2 parts of theanine, 0.5 to 2 parts of astaxanthin, 0.5 to 2 parts of lycopene, 0.5 to 2 parts of resveratrol, 0.5 to 2 parts of curcumin, 0.1 to 1 part of EPA, 0.1 to 1 partof DHA, 0.1 to 1 part of cyaniding, and 0.1 to 1 part of delphinidin. Therefore, the synergistic interaction effect can be realized in the aspect of reducing the blood pressure and the blood pressureof a hypertension patient is effectively reduced, so that the blood pressure of the hypertension patient is kept in a stable state for long time; the synergistic interaction of reducing the cholesterol and blood fat and improving the antioxidant function can be realized; the blood vessel function is improved; the organism immunity is enhanced; substances that are deposited in blood vessels and capable of blocking the blood vessels are removed; and the occurrence and development of hypertension are relieved and improved.
Description
technical field [0001] The invention relates to the fields of medicines, health care products or food, in particular to a composition with blood pressure lowering effect and its application. Background technique [0002] Hypertension is the most common chronic disease and the main risk factor for cardiovascular and cerebrovascular diseases, which can easily lead to coronary heart disease, stroke, congestive heart failure and renal dysfunction. Hypertension is characterized by one-time illness and life-long medication. In recent years, with social progress, economic development, personal income increases, life gradually affluent, food fat and calories increase, transportation developed, physical activity decreased, the incidence of hypertension in my country has been increasing year by year. [0003] The current medicines for the treatment of hypertension include chemically synthesized medicines and Chinese patent medicines. Commonly used chemical synthetic drugs include: d...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more